Clinical Trials
90
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (89 trials with phase data)• Click on a phase to view related trials
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Conditions
- AnemiaChronic Kidney DiseaseChronic Kidney Disease Patients on HemodialysisChronic Kidney Disease 5D
- Interventions
- Biological: BCD-131 (pegdarbepoetin beta)Biological: Mircera (methoxypolyethylene glycol-epoetin beta)
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Biocad
- Target Recruit Count
- 228
- Registration Number
- NCT07119372
- Locations
- 🇧🇾
Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Belarus
🇷🇺B. Braun Avitum Russland Clinics Ltd., Saint Petersburg, Russian Federation
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
- Conditions
- Triple Negative Breast Cancer
- Interventions
- Drug: Chemotherapy
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Biocad
- Target Recruit Count
- 124
- Registration Number
- NCT07108309
- Locations
- 🇧🇾
Health Institution "Brest Regional Oncology Center", Brest, Belarus
🇧🇾"Gomel Regional Clinical Oncology Dispensary", Gomel, Belarus
🇧🇾Minsk City Oncology Center, Minsk, Belarus
A Randomized Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
- Conditions
- Ulcerative Colitis (UC)
- Interventions
- Biological: anti-TL1A monoclonal antibody, low doseBiological: anti-TL1A monoclonal antibody, high doseOther: PlaceboBiological: anti-TL1A monoclonal antibody, medium dose
- First Posted Date
- 2025-07-23
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- Biocad
- Target Recruit Count
- 198
- Registration Number
- NCT07080034
- Locations
- 🇷🇺
LLC Medical Center "ASTRA", Barnaul, Altai Krai, Russian Federation
🇷🇺Republican Clinical Hospital named after G.G. Kuvatov, Ufa, Republic of Bashkortostan, Russian Federation
🇷🇺State Autonomous Institution of Healthcare "Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan", Kazan, Republic of Tatarstan, Russian Federation
Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
- Conditions
- Crohn's Disease (CD)
- Interventions
- Biological: anti-TL1A monoclonal antibody, low doseOther: PlaceboBiological: anti-TL1A monoclonal antibody, medium doseBiological: anti-TL1A monoclonal antibody, high dose
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Biocad
- Target Recruit Count
- 204
- Registration Number
- NCT07078994
- Locations
- 🇷🇺
LLC Medical Center "ASTRA", Barnaul, Altai Krai, Russian Federation
🇷🇺Republican Clinical Hospital named after G.G. Kuvatov, Ufa, Republic of Bashkortostan, Russian Federation
🇷🇺State Autonomous Institution of Healthcare "Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan", Kazan, Republic of Tatarstan, Russian Federation
An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN
- Conditions
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Interventions
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Biocad
- Target Recruit Count
- 24
- Registration Number
- NCT06987864
- Locations
- 🇷🇺
Territorial State Budgetary Healthcare Institution "Territorial Clinical Hospital", Barnaul, Russian Federation
🇷🇺State Autonomous Healthcare Institution "S.V. Belyaev Kuzbass Regional Clinical Hospital", Kemerovo, Russian Federation
🇷🇺Federal State Budgetary Institution of Science "Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency", Kirov, Russian Federation
- Prev
- 1
- 2
- 3
- 4
- 5
- 18
- Next